BCBSM/BCN Dual Header The Record Header Logo

The Record - Insurance Card with the BCBSM/BCN Cross and Shield logo that reads, Blue Cross Blue Shield, Blue Care Network of Michigan. Tagline: Confidence comes with every card. Image of Note boards with paper that has the letters RX on it accompanied by a stethoscope

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article
July 2018

Effective July 1, use new procedure code Q9993 when billing for Zilretta®

Effective July 1, 2018, the Center for Medicare & Medicaid Services has established a new procedure code for Zilretta, or triamcinolone acetonide.

All injection services for Zilretta from Oct. 9, 2017, through June 30, 2018, will continue to be reported with procedure code J3490. All injection services performed on or after July 1, 2018, must be reported with procedure code Q9993.

The National Drug Code for Zilretta is 70801-0003-01.

Zilretta continues to be covered for the FDA-approved indications as establisted on Oct. 9, 2017. The U.S. Food and Drug Administration approved Zilretta for the management of osteoarthritis pain of the knee.

This drug doesn’t require prior authorization from Blue Cross Blue Shield of Michigan.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2017 American Medical Association. All rights reserved.
Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and
independent licensees of the Blue Cross and Blue Shield Association.